Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 2023 (7) TMI AT This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2023 (7) TMI 580 - AT - Central Excise


Issues:
Valuation of physician samples for excise duty under Central Excise Act, 1944 and Central Excise Valuation Rules, 2000.

Issue 1: Valuation of physician samples under Central Excise Act, 1944 and Central Excise Valuation Rules, 2000

The case involved a manufacturer of P or P Medicines appealing against the order upholding the valuation of physician samples for excise duty under section 4A of the Central Excise Act, 1944. The appellant contended that physician samples, not meant for sale and not required to be affixed with MRP, should not be valued under section 4A. The department issued a show cause notice demanding excise duty based on the difference in valuation. The Assistant Commissioner upheld the demand under Rule 4 of Central Excise Valuation Rules 2000. The Commissioner (Appeals) also affirmed the decision, citing that even if samples are for marketing, once MRP is mentioned, valuation should be as per MRP under section 4A. The appellant's argument that valuation should be under Rule 11 read with Rule 8 of Central Excise Valuation Rules 2000 was rejected. The Tribunal referred to the decisions in Cadila Pharmaceuticals Ltd. and Medley Pharmaceuticals Ltd., where it was held that physician samples should be valued on a pro-rata basis. The appellant's method of valuation adding 15% profit was not accepted, leading to the dismissal of the appeal.

Conclusion:
The appeal challenging the valuation of physician samples for excise duty under the Central Excise Act, 1944 and Central Excise Valuation Rules, 2000 was dismissed based on the precedents and legal interpretations provided by the Tribunal and the Supreme Court.

 

 

 

 

Quick Updates:Latest Updates